American Portfolios Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-4,077
| Closed | -$344K | – | 2855 |
|
|
2019
Q2 | $344K | Buy |
4,077
+224
| +6% | +$18.9K | 0.03% | 526 |
|
|
2019
Q1 | $368K | Buy |
3,853
+1,122
| +41% | +$107K | 0.03% | 449 |
|
|
2018
Q4 | $193K | Buy |
+2,731
| New | +$193K | 0.02% | 521 |
|
|
2018
Q3 | – | Sell |
-1,637
| Closed | -$190K | – | 2429 |
|
|
2018
Q2 | $190K | Buy |
1,637
+784
| +92% | +$90.9K | 0.03% | 568 |
|
|
2018
Q1 | $69K | Buy |
853
+92
| +12% | +$7.44K | 0.01% | 895 |
|
|
2017
Q4 | $44.7K | Buy |
+761
| New | +$44.7K | 0.01% | 1041 |
|